4//SEC Filing
Campbell David Alan 4
Accession 0001415889-24-028203
CIK 0001817713other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 8:00 PM ET
Size
4.9 KB
Accession
0001415889-24-028203
Insider Transaction Report
Form 4
Campbell David Alan
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-03$67.00/sh−15,000$1,005,000→ 242,054 total
Footnotes (1)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2024.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001864158
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 8:00 PM ET
- Size
- 4.9 KB